BODY + MIND INC.

Profile

Company Names

BODY + MIND INC.
DEPLOY TECHNOLOGIES INC

Addresses

750 - 1095 WEST PENDER STREET, VANCOUVER, A1 V6E 2M6

Phone Numbers

604-376-3567

 

Entity Type:

CORPORATION

Industry:

OTHER

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$27,751,821.00

Number of Funding Rounds:

16
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
16
2024-11-07 
$99,965.00 
$99,965.00 
$0.00 
Equity 
15
2024-02-09 
$178,527.00 
$178,527.00 
$0.00 
Equity 
14
2023-04-25 
$0.00 
$205,132.00 
$205,132.00 
 
13
2022-12-21 
$979,467.00 
$979,467.00 
$0.00 
Equity 
12
2022-12-19 
$3,000,000.00 
$4,500,000.00 
$1,500,000.00 
Equity 
11
2022-12-07 
$2,184,427.00 
$2,184,427.00 
$0.00 
Equity 
10
2022-07-15 
$75,000.00 
$75,000.00 
$0.00 
Equity 
9
2022-06-14 
$0.00 
$160,000.00 
$160,000.00 
 
8
2021-12-03 
$998,228.00 
$998,228.00 
$0.00 
Equity 
7
2021-09-21 
$472,196.00 
$472,196.00 
$0.00 
Equity 
6
2021-07-19 
$6,666,667.00 
$10,026,667.00 
$3,360,000.00 
Debt 
5
2020-10-21 
$311,719.00 
$311,719.00 
$0.00 
Equity 
4
2020-07-01 
$1,174,080.00 
$1,174,080.00 
$0.00 
Equity 
3
2019-05-17 
$1,097,793.00 
$5,000,464.00 
$3,902,671.00 
Equity 
2
2017-11-14 
$9,460,142.00 
$9,460,142.00 
$0.00 
Equity 
1
2017-08-15 
$1,053,610.00 
$2,490,350.00 
$1,436,740.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LEONARD 
 
CLOUGH 
EXECUTIVE OFFICER, DIRECTOR
SCOTT 
 
DOWTY 
DIRECTOR
ROBERT 
 
HASMAN 
DIRECTOR
STEPHEN 
AUGUST 
HOFFMAN 
EXECUTIVE OFFICER, DIRECTOR
TRIP 
 
HOFFMAN 
EXECUTIVE OFFICER
KEVIN 
 
HOOKS 
DIRECTOR
CHRIS 
 
MACLEOD 
DIRECTOR
MICHAEL 
 
MILLS 
EXECUTIVE OFFICER, DIRECTOR
ALEXIS 
 
PODESTA 
DIRECTOR
BRENT 
 
REUTER 
DIRECTOR
BRENT 
EDWIN 
REUTER 
DIRECTOR
DONG HYUN 
 
SHIM 
EXECUTIVE OFFICER, DIRECTOR
DARREN 
 
TINDALE 
EXECUTIVE OFFICER, DIRECTOR
DAVID 
 
WENGER 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-11-07 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-02-09 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2023-04-25 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-12-19 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-12-21 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-12-07 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-07-15 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2022-06-14 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-12-03 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-09-21 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-07-19 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-10-21 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-07-01 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-05-17 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-14 
D
OTHER 
 
DECLINE TO DISCLOSE 
 
2017-08-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#